Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Florian Krammer(Icahn School of Medicine at Mount Sinai), Hisaaki Kawabata(Icahn School of Medicine at Mount Sinai), Komal Srivastava(Icahn School of Medicine at Mount Sinai), Harm van Bakel(Icahn School of Medicine at Mount Sinai), Hala Alshammary(Icahn School of Medicine at Mount Sinai), Ariel Raskin(Icahn School of Medicine at Mount Sinai), Ana S. Gonzalez‐Reiche(Icahn School of Medicine at Mount Sinai), Goran Bajic(Icahn School of Medicine at Mount Sinai), Johnstone Tcheou(Icahn School of Medicine at Mount Sinai), Gagandeep Singh(Icahn School of Medicine at Mount Sinai), Levy A. Sominsky(Icahn School of Medicine at Mount Sinai), Dominika Bielak(Icahn School of Medicine at Mount Sinai), Emilia Mia Sordillo(Mount Sinai Health System), D. Noah Sather(University of Washington), Viviana Simon(Icahn School of Medicine at Mount Sinai), J. B. Clark(Icahn School of Medicine at Mount Sinai), Daniel C. Adelsberg(Icahn School of Medicine at Mount Sinai), Nicholas Dambrauskas(Infectious Disease Research Institute), Vladimir Vigdorovich(Infectious Disease Research Institute)
Cited by 100
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803